KALY Evaluates Patented Cannabis Extract For Potential Coronavirus Treatment
March 02 2020 - 9:16AM
InvestorsHub NewsWire
KALY Evaluates Patented Cannabis
Extract For Potential Coronavirus Treatment
Dallas, TX -- March 2, 2020 -- InvestorsHub NewsWire
-- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.)
(USOTC:
KALY) (“KALY”) today again confirmed efforts to evaluate its
proprietary CBD extract formulation as a treatment for coronavirus
symptoms. KALY’s proprietary CBD formulation
has been developed for the treatment of symptoms associated
with Chronic Obstructive Pulmonary Disease
(COPD) and other similar respiratory
conditions. The formulation for the
treatment of symptoms associated with COPD and other similar
respiratory conditions has been derived from the company’s U.S.
Patented Cannabis Extraction Process. As detailed in a recently
published research study (Journal of Cannabis Research) the KALY
U.S. Patented CBD extract provides significant anti-inflammatory
responses in vitro. The next phase of
research is now moving forward in
preclinical in vivo research to expand
evaluation of the effects on lung function, total body
distribution, whole body clearance of the extract and dosage
evaluations for maximal efficacy. KALY has filed a new patent
application specifically on its CBD formulation for symptoms
associated with COPD and other similar respiratory
conditions. KALY has also filed for a
trademark on the name RespRx as the
brand name for its CBD formulation to treat the symptoms associated
with COPD and other similar respiratory conditions that result
from respiratory
inflammation.
To learn more about RespRx,
visit https://www.resprx.com/
Follow further
developments at
https://www.kali-extracts.com/
This press
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and as such, may involve risks and uncertainties.
These forward looking statements relate to, amongst other things,
current expectation of the business environment in which the
company operates, potential future performance, projections of
future performance and the perceived opportunities in the market.
The company's actual performance, results and achievements may
differ materially from the expressed or implied in such
forward-looking statements as a result of a wide range of
factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214)
210-0459
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Apr 2023 to Apr 2024